Overdiagnosis and Lung Cancer Screening
Overdiagnosis is the diagnosis of “disease” that will never cause symptoms or death during a patient’s lifetime.

Recent results of the NELSON Lung Cancer Screening Trial reports reductions in lung-cancer survival but not overall survival – The desire to detect disease even earlier means Overdiagnosis is on the rise, however, the interpretation of screening trial results is problematic and often gives rise to significant uncertainties that go unanswered.

Carl Heneghan, Professor of Evidence-Based Medicine, employs evidence-based methods to research diagnostic reasoning, test accuracy and communicating diagnostic results to a wider audience.

This talk is being held as part of the Evidence-Based Diagnosis & Screening module which is part of the MSc in Evidence-Based Health Care and the MSc in EBHC Medical Statistics. Members of the public are welcome to attend.
Date: 10 February 2020, 17:00 (Monday, 4th week, Hilary 2020)
Venue: Rewley House, 1-7 Wellington Square OX1 2JA
Venue Details: Lecture Theatre
Speaker: Prof Carl Heneghan (CEBM Oxford University)
Organising department: Department for Continuing Education
Organiser: Robin Beachy (University of Oxford, Department for Continuing Education)
Organiser contact email address: cpdhealthadmin@conted.ox.ac.uk
Part of: Evidence-Based Health Care Programme
Topics:
Booking required?: Recommended
Booking url: https://overdiagnosis-lung-cancer-screening.eventbrite.co.uk
Cost: Free
Audience: Public
Editor: Robin Beachy